News|Articles|February 26, 2025
Advanced LC-MS Technology for Enhanced HCP Detection in Complex Biotherapeutics
Author(s)Samsung Biologics
The identification, characterization, and quantitation of host cell protein (HCP) impurities are a critical challenge in the biopharmaceutical industry. Advanced LC-MS techniques can be integrated into manufacturing workflows to mitigate risks and ensure higher product quality and improved patient safety.
Related Content
Sponsored Content
Trending on Pharmaceutical Technology
1
PharmTech Weekly Roundup–July 10, 2026
2
The Implications of Isatuximab-irfc’s FDA Approval for Multiple Myeloma
3
The FDA Moves to Modernize Drug Manufacturing Registration
4
What the Ocrelizumab Deal Does for the Multiple Sclerosis Biosimilar Pipeline
5